Ackermann v. Wyeth Pharmaceuticals
Court of Appeals for the Fifth Circuit
1Opinion of the Court
EDITH H. JONES, Chief Judge:
Appellant Rozlyn Ackermann (“Ackermann”) challenges the district court’s grant of summary judgment dismissing her claim that Wyeth Pharmaceuticals (“Wyeth”) failed adequately to warn about the drug-induced risk of suicide from its drug Effexor, and this deficiency led to her husband’s suicide. Because Ackermann has failed to demonstrate causation under the learned-intermediary doctrine, we affirm.
I. BACKGROUND
In November 2001, Martin Ackermann (“Martin”), a . 53-year-old businessman, suffered from clinical depression brought on by severe business and family…
2Cases cited24 opinions
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Uniroyal Goodrich Tire Co. v. MartinezTexas Supreme Court · 1998
- Mary Faye Skotak, George Jerry Skotak, and Eric Norman Skotak, Cross-Appellees v. Tenneco Resins, Inc., Cross-AppellantCourt of Appeals for the Fifth Circuit · 1992
- Alm v. Aluminum Co. of AmericaTexas Supreme Court · 1986
- Union Pump Co. v. AllbrittonTexas Supreme Court · 1995
19 more not listed; retrieve them via the Exa API.
3Cited by51 opinions
- Christopher v. Depuy Orthopaedics, Inc. (In Re Depuy Orthopaedics, Inc., Pinnacle Hip Implant Prod. Liab. Litig.)Court of Appeals for the Fifth Circuit · 2018
- Walton v. Bayer CorporationCourt of Appeals for the Seventh Circuit · 2011
- Gagnon v. United Technisource, Inc.Court of Appeals for the Fifth Circuit · 2010
- Wells v. SmithKline Beecham Corp.Court of Appeals for the Fifth Circuit · 2010
- Evelyn Nye v. Bayer Cropscience, Inc.Tennessee Supreme Court · 2011
46 more not listed; retrieve them via the Exa API.